Skip to content

Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast Cancer

The Second Xiangya Hospital of Central South University

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07185646
Enrollment
200
Registered
2025-09-22
Start date
2023-01-01
Completion date
2030-12-30
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRI Imaging, Neuro-Oncology, Tumor Immune Microenvironment

Brief summary

The objective of this observational study is to investigate the characteristics of the tumor microenvironment in patients with brain tumors using multi-modal magnetic resonance imaging (MRI). The primary research question it aims to address is: • Can multi-modal MRI effectively characterize features of the immune microenvironment in brain tumor patients? Participants: Eligible participants who have been diagnosed with a brain tumor will undergo multi-modal MRI scans for detailed assessment of tumor microenvironment features.

Interventions

None listed

Sponsors

Second Xiangya Hospital of Central South University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. conventional MRI revealed intracranial space-occupying lesions and suspected high-grade gliomas, brain metastases and meningiomas; 2. It is planned to perform a brain tumor resection surgery in this institution.

Exclusion criteria

1. other CNS diseases in addition to brain tumors; 2. pathologically confirmed brain tumors not belonging to any of the three selected types; 3. contraindications to the use of gadolinium contrast, including hypersensitivity to contrast agents, renal dysfunction, pregnancy or lactation; 4. contraindications to MRI; 5. poor image quality unsuitable for subsequent analyses; 6. age younger than 18 years.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Progression-Free Survival6months,12months,24monthsPostoperative Progression-Free Survival is defined as the time interval from the date of surgical intervention until the first occurrence of either documented disease progression or death from any cause

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026